fosfestrol has been researched along with Edema* in 1 studies
1 other study(ies) available for fosfestrol and Edema
Article | Year |
---|---|
Adverse effects during endocrine therapy for prostatic carcinoma with a high dose of estrogen.
A clinical study of the adverse effects induced by the endocrine therapy with a high dose of estrogen in 45 patients with stage C or D prostatic carcinoma is conducted. Transient decreases of hemoglobin and serum protein values were observed after administration of estrogen. The levels of glutamine-oxaloacetic and glutamic-pyruvic transaminase showed a transient increase. The value of serum total cholesterol and electrolytes showed no changes. Serial evaluations of electrocardiograms have played a minor role in the observation of cardiovascular disease. Up to date we have not experienced cardiovascular death in our cases during the endocrine therapy. Topics: Aged; Antineoplastic Agents; Castration; Cholesterol; Combined Modality Therapy; Diethylstilbestrol; Dose-Response Relationship, Drug; Edema; Electrocardiography; Electrolytes; Hemoglobinometry; Humans; Injections, Intravenous; Intracranial Embolism and Thrombosis; Male; Middle Aged; Prostatic Neoplasms | 1985 |